vimarsana.com
Home
Live Updates
Edwards Lifesciences says TAVR drove 12% sales growth in Q3
Edwards Lifesciences says TAVR drove 12% sales growth in Q3
Edwards Lifesciences says TAVR drove 12% sales growth in Q3
Edwards Lifesciences reported Q3 results that met Wall Street expectations. It remains on track to boost sales by up to 13% this year.
Related Keywords
Japan ,
California ,
United States ,
San Francisco ,
Irvine ,
Japanese ,
Edwards Lifesciences ,
Bernard Zovighian ,
Larry Wood ,
European Commission ,
European Union ,
Wall Street ,
Cardiovascular Therapeutics ,
Pascal Precision ,